Philips Medical Imaging System Recalled for Motorized Movement Risk
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Hazard Information
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
Product Details
The recalled product is the Allura CV20 with Product Code: 722031. It was distributed globally, including the US and countries like Australia, Canada, and Germany. The specific model numbers include various serial numbers, with a total quantity of 46 units.
The Hazard
The imaging systems may not perform as intended due to the deterioration of the CMOS battery, hard disk drive, and/or power supply unit. This deterioration can cause a loss of motorized movements while keeping manual and imaging functionalities operational.
Reported Incidents
There have been no reported injuries or incidents related to this recall. The potential risk involves the loss of motorized movements, which could affect patient care.
What to Do
Stop using the device immediately. Contact Philips Medical Systems Nederland B.V. or your healthcare provider for further instructions.
Contact Information
For more information, visit https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2635-2025. Philips Medical Systems can be contacted directly for specific inquiries.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.